Improving health and reducing inequities worldwide


Session Descriptions | The Science of Global Health: What’s Next

Event page: The Science of Global Health: What's Next »


8:30 – 8:45 am

  • Jaime Sepulveda, Executive Director, Global Health Sciences
  • Sam Hawgood, Chancellor, UCSF

Keynote: Equity and progress in global health

8:45 – 9:00 am

Equity is both a goal of global health and a means to achieving greater progress in health. While mortality overall, and especially deaths in children, has fallen rapidly in many low and middle income countries, many inequities within countries have worsened. Future progress in global health will depend on both raising the average standards for health in the least advantaged countries and reducing inequities in health and wellbeing within all countries.

  • Harvey Fineberg, UCSF Presidential Chair and Visiting Professor, UCSF

Panel: The age of pandemics: the need for global collective action

9:00 – 10:00 am

Ebola, SARS, MERS, H1N1…. The news cycle highlights just how a rapidly globalizing world can produce threats to health across borders. Experts will discuss the latest efforts to prepare for future pandemics and suggest what governments must do to protect their citizens.

  • Moderator: Richard Feachem, Director, Global Health Group, UCSF
  • Larry Brilliant, President and Senior Adviser to Jeff Skoll, Skoll Global Threats Fund
  • Dan Kelly, Clinical Fellow, UCSF
  • Ramanan Laxminarayan, Vice President, Research and Policy, Public Health Foundation of India

Insider conversation: Essential surgery

10:00 – 10:20 am

According to the Lancet Commission on Global Surgery, more than 2 billion people worldwide lack access even to basic surgical care. Lack of access to surgery can create permanent incapacities, with an estimated 11-15% of disability in the world due to surgically treatable conditions. Learn what is being done to make essential surgical services available to the world's poorest populations.

  • Moderator: Gavin Yamey, Lead, Evidence to Policy Initiative, UCSF
  • Haile Debas, Director, UC Global Health Institute
  • Paul Farmer, Kolokotrones University Professor of Global Health and Social Medicine, Harvard University

Panel: The unfinished agenda of neglected tropical diseases

10:40 – 11:40 am

For many years, neglected tropical diseases have been just that: neglected. However a wave of new funding combined with novel tools are generating significant progress against conditions that afflict the most vulnerable populations. Come learn about major breakthroughs on the horizon for these tragic diseases.

  • Moderator: Mary Wilson, Visiting Professor, UCSF
  • Eva Harris, Professor and Director, Center for Global Public Health, UC Berkeley
  • Peter Hotez, Founding Dean, National School of Tropical Medicine, Baylor College of Medicine
  • Mark Rosenberg, President and CEO, The Task Force for Global Health
  • Roberto Tapia Conyer, Director General, Carlos Slim Foundation

Panel: Preterm birth: reversing the trend together

11:40 am – 12:40 pm

One of the greatest global health accomplishments of the last 20 years has been the progress in reducing the death rate of children under five years of age. However, the death rate among newborns has not declined as quickly, due largely to the rising epidemic of preterm births. The panel will discuss new tools and approaches to combat this problem in global and local settings.

  • Moderator: Larry Rand, co-Director, PTBi, Perinatal Director, Fetal Treatment Center and Benioff Endowed Chair in Maternal Fetal Medicine, UCSF
  • Zulfiqar Bhutta, Founding Director, Center of Excellence in Women and Child Health, The Aga Khan University
  • Mariam Claeson, Director, Maternal Newborn and Child Health, Bill & Melinda Gates Foundation
  • Jennifer Howse, President, March of Dimes
  • Paul Wise, Richard E. Behrman Professor of Child Health and Society and Professor of Pediatrics and Health Policy, Stanford University

Insider conversation: Global health funding

1:40 – 2:00 pm

Over the last 20 years, international funding flows for health have increased to nearly $30 billion per year. However, funding for global health faces a number of transitions as additional areas seek support and the rising wealth in low-income countries is leading international donors to shift a greater share of the cost to domestic purses. Come hear leading experts discuss the future of global health funding and how it might affect research activities.

  • Moderator: Dean Jamison, Senior Fellow and Health Economist, UCSF
  • Roger Glass, Director, Fogarty International Center, National Institutes of Health
  • Peter Singer, CEO, Grand Challenges Canada

Panel: Understanding and measuring what works

2:00 – 3:00 pm

There has been a revolution in recent years in the way health is measured, and this revolution promises to change how resources are allocated, how care is delivered, and who benefits from this investment. The panelists will discuss new findings on the global burden of disease and what it implies for academic global health researchers, clinical caregivers, policymakers, donors and others.

  • Moderator: George Rutherford, Director, Prevention & Public Health Group, UCSF
  • Stefano Bertozzi, Dean, School of Public Health, UC Berkeley
  • Julio Frenk, Dean, School of Public Health, Harvard University
  • Joy Lawn, Director, MARCH Centre, London School of Hygiene & Tropical Medicine
  • Chris Murray, Director, Institute for Health Metrics and Evaluation

Panel: Product development and delivery in global health

3:20 – 4:20 pm

Innovative new products have completely transformed how we prevent and treat conditions like HIV, malaria, meningitis, hepatitis, diarrheal disease, and respiratory infection, saving countless lives. And yet, the challenges to successful innovation in life sciences continue to rise. Come hear leaders describe what is needed to enable biomedical science to be translated into life-saving products.

  • Moderator: Colin Boyle, Deputy Director, Global Health Sciences, UCSF
  • Chris Elias, President, Global Development Program, Bill & Melinda Gates Foundation
  • John Martin, Chairman & CEO, Gilead Sciences
  • Bill Rutter, Chairman & CEO, Synergenics, LLC
  • Tachi Yamada, Executive Vice President and Chief Medical & Scientific Officer, Takeda Pharmaceuticals

Insider conversation: Rwanda — what is replicable?

4:20 – 4:40 pm

No country in human history has reduced mortality rates as quickly as Rwanda in the last 15 years. But are the circumstances that have allowed Rwanda to make this progress unique? Ambassador Eric Goosby will moderate a discussion with the Rwandan Minister of Health and Paul Farmer about what is replicable from Rwanda and what other countries might learn from its experience.

  • Moderator: Eric Goosby, Director, Institute for Global Health Delivery & Diplomacy at UCSF and Former U.S. Global AIDS Coordinator
  • Paulin Basinga, Senior Program Officer, Bill & Melinda Gates Foundation
  • Paul Farmer, Kolokotrones University Professor of Global Health and Social Medicine, Harvard University

Closing remarks & final thoughts

4:40 – 5:00 pm

  • Lincoln Chen, President, China Medical Board
  • Jaime Sepulveda, Executive Director, Global Health Sciences, UCSF

Event page: The Science of Global Health: What's Next »
Frequently asked questions »